Anabel Chan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IMMUNOGEN, INC. | Investor Relations Contact | - | - |
Career history of Anabel Chan
Statistics
International
| United States | 2 |
Operational
| Investor Relations Contact | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Anabel Chan
- Experience
